Alkosign IPO vs Vaidya Sane Ayurved Laboratories IPO

Comparison between Alkosign IPO and Vaidya Sane Ayurved Laboratories IPO.

IPO Details

Alkosign IPO is a SME Fixed Price IPO proposed to list at BSE SME while Vaidya Sane Ayurved Laboratories IPO is a SME Fixed Price proposed to list at NSE SME.

Issue Size and Price

The total issue size of Alkosign IPO is up to ₹11.53 Cr whereas the issue size of the Vaidya Sane Ayurved Laboratories IPO is up to ₹19.20 Cr. The final issue price of Alkosign IPO is ₹45.00 per share and of Vaidya Sane Ayurved Laboratories IPO is ₹73.00 per share.

 Alkosign IPOVaidya Sane Ayurved Laboratories IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final)₹45.00 per share₹73.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Discount (Employee)
Market Lot Size3000 shares1600 shares
Fresh Issue Size25,62,000 shares26,30,400 shares
Fresh Issue Size (Amount)up to ₹11.53 Crup to ₹19.20 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total25,62,000 shares26,30,400 shares
Issue Size Total (Amount)up to ₹11.53 Crup to ₹19.20 Cr

IPO Timetable

Alkosign IPO opens on Jan 18, 2022, while Vaidya Sane Ayurved Laboratories IPO opens on Feb 10, 2022. The closing date of Alkosign IPO and Vaidya Sane Ayurved Laboratories IPO is Jan 21, 2022, and Feb 15, 2022, respectively.

Financials & KPIs

Alkosign IPO P/E ratio is , as compared to Vaidya Sane Ayurved Laboratories IPO P/E ratio of 28.29.

 Alkosign IPOVaidya Sane Ayurved Laboratories IPO
Financials

Company Financials ()

Period Ended
Amount in ₹ Crore

Company Financials ()

Period Ended
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)100.0090.08
Promoter Shareholding (Post-Issue)50.4166.34
P/E Ratio28.29
Market Cap₹24.50 Cr.₹76.75 Cr.
ROE197
ROCE13
Debt/Equity30.46
EPS₹10.86₹2.22
RoNW98.5115.84

Shares Offered

In the Alkosign IPO Retail Individual Investors (RII) are offered 12,81,000 shares while in Vaidya Sane Ayurved Laboratories IPO retail investors are offered 12,81,000 shares. Qualified Institutional Buyers (QIB) are offered in Alkosign IPO and in Vaidya Sane Ayurved Laboratories IPO.

 Alkosign IPOVaidya Sane Ayurved Laboratories IPO
Anchor Investor Reservation
Market Maker Reservation1,38,000 shares1,40,800 shares
QIB
NII12,81,000 shares13,15,200 shares
RII12,81,000 shares13,15,200 shares
Employee
Others
Total25,62,000 shares26,30,400 shares

Bids Received (Subscription)

Alkosign IPO subscribed 4.76x in total, whereas Vaidya Sane Ayurved Laboratories IPO subscribed 2.82x.

Compare with others

Compare: